Theranostics Journal Citation Rate 2026
1838-7640
Ivyspring International Publisher
AU
Q1 Quartile Open Access Top Tier
About Theranostics
Theranostics (T) is a peer-reviewed academic journal covering Extracellular vesicles in disease and MicroRNA in disease regulation, published by Ivyspring International Publisher in AU, catalogued under ISSN 1838-7640. As of 2026, it has a 2025 2-Year Citation Rate (OpenAlex) of 10.23 (Q1 quartile) — the average number of citations its recent articles received over a two-year window, computed from OpenAlex open citation data, not the Clarivate (JCR) Impact Factor. It is fully open access, with an Article Processing Charge (APC) of approximately $1671 USD. OpenAlex records 5,585 works and 364,646 citations, with an h-index of 228.
Theranostics Citation Rate 2026 — In Context
Theranostics has a 2025 2-Year Citation Rate (OpenAlex) of 10.23, placing it in the Q1 quartile within the Extracellular vesicles in disease research area. This is the average number of citations the journal's recent articles received over a two-year window, computed from OpenAlex open citation data — not the Clarivate (JCR) Journal Impact Factor.
As a fully open-access publication, Theranostics makes all articles freely available to readers for an Article Processing Charge of approximately $1671 USD.
Researchers looking to publish in Theranostics should review the journal's submission tips and verify the latest indexing status against Scopus, DOAJ, and Web of Science using our indexing tracker. To compare Theranostics against similar journals in the field, use our journal comparison tool.
Submission Tips for Theranostics
- Budget $1671 for the Article Processing Charge. Check if your institution or funder covers OA fees.
- This journal covers Extracellular vesicles in disease, MicroRNA in disease regulation, Nanoparticle-Based Drug Delivery. Ensure your manuscript aligns with these scope areas to avoid desk rejection.
How Theranostics Compares
Compared against 54 journals in the same research areas.
| ISSN (Print) | 1838-7640 |
|---|---|
| Publisher | Ivyspring International Publisher |
| Country | Australia |
| APC / Cost | $1671 USD |
| h-index | 230 |
| Total Works | 5,597 |
| Total Citations | 372,058 |
| 2-yr Mean Citedness | 13.76 (OpenAlex) |
| DOAJ | Listed |
In-depth profile & metrics
Theranostics is published by Ivyspring International Publisher and based in Australia. It publishes open access with an article-processing charge of USD 1671.
In our subject taxonomy, Theranostics is classified under Extracellular vesicles in disease, MicroRNA in disease regulation, Nanoparticle-Based Drug Delivery and Nanoplatforms for cancer theranostics.
Theranostics is indexed in the DOAJ and OpenAlex. DOAJ listing confirms the journal's open-access policies have been independently vetted.
OpenAlex records 5,597 works that have together drawn 372,058 citations, giving the journal an h-index of 230; its most recent citation rate stands at 10.229; OpenAlex puts its two-year mean citedness at 13.76.
Research Areas
Links
Continue on JournalsHub
Put what you just read into practice with these free tools.
Frequently Asked Questions about Theranostics
Live Indexing Status
Updated April 2026Track real-time indexing metrics to ensure this journal meets your academic requirements.
Citation Rate
Historical Trend
Initial data points onlyCitation Rate by Year
| Year | Value | Source |
|---|---|---|
| 2025 | 10.229 | 2-Year Mean Citedness (OpenAlex) |
Metrics are sourced from OpenAlex, DOAJ and Scopus and reflect the latest data we hold. The headline figure is a 2-year citation rate (OpenAlex), not a Clarivate Impact Factor. Always verify against the journal's official site before relying on it. See our Methodology or report a correction.
Works Published per Year (2014–2025)
Annual publication volume sourced from OpenAlex. Current year omitted (partial data).
Publication & citation history by year
| Year | Works published | Citations received |
|---|---|---|
| 2025 | 571 | 5,740 |
| 2024 | 458 | 12,011 |
| 2023 | 332 | 14,369 |
| 2022 | 448 | 25,607 |
| 2021 | 534 | 41,390 |
| 2020 | 871 | 74,286 |
| 2019 | 613 | 53,953 |
| 2018 | 413 | 39,185 |
| 2017 | 399 | 37,345 |
| 2016 | 197 | 20,864 |
| 2015 | 119 | 12,425 |
| 2014 | 117 | 11,753 |
Journal at a Glance
Source: OpenAlex — refreshed daily.
Top Research Topics
The areas where Theranostics most frequently publishes, ranked by article volume. Click a topic to see the best journals for it.
Compare Journals
Compare Theranostics against similar publications in its field:
Related Journals in Your Field
-
Cell Death and Disease Springer Nature IF 64.50
-
DNA and Cell Biology Mary Ann Liebert IF 64.50
-
Frontiers in Cell and Developmental Biology Frontiers Media SA IF 64.50
-
Experimental Cell Research Elsevier IF 64.50
-
Cancer Cell International Springer Nature IF 64.50
Explore More Journals
Metadata
Last updated: Apr 24, 2026
Updated by: openalex_bulk
OpenAlex ID: S2482500137
Get weekly updates for Extracellular vesicles in disease journals
Free. Monday morning. New citation rates, CFPs, indexing alerts, predatory watch list. One-click unsubscribe.